Dr. Min Seob Lee

CEO, Founder and Chairman

Dr. Min Seob Lee is the CEO of Diagnomics Lab, in San Diego, CA. He also serves as the CEO of the Eone Diagnomics Genome Center (KOSDAQ; EDGC) in Incheon South Korea. He is a visiting professor of Institute of Convergence Science & Technology in Incheon National University and a director of ShareGenome in California that promotes research in precision medicine and scientific discoveries from genomics and health data. Dr. Lee is a writer of the “Homo Hundred Genome Revolution” book and published numerous scientific articles.

Dr. Lee has established multiple companies and institutes in Genomics and Personalized Medicine industries globally. He is a world-renowned scholar, researcher and entrepreneur in Genomics and outstanding leader in healthcare and bio-tech industries and its implementation for personalized medicine and diagnostics development for precision medicine. He has extensive global experience and presence in the life sciences, healthcare and IT business area including bio-tech, pharmaceutical and diagnostics companies with expertise in personal genomics, big-data processing, artificial intelligence (AI), pharmacogenomics, bioinformatics and molecular diagnostics. Prior to his current role and responsibilities, he held several positions at Sequenom in San Diego, CA and Genaissance Pharmaceuticals in New Haven, CT within their diagnostic development and genomics lab operations.

He has been granted many US, Korea and international patents in the area of personalized medicine, genomics and diagnostic development. He conducted his post-doctoral fellowship at the Genomics and Proteomics Center at Harvard Medical School and Beth Israel Deaconess Medical Center and received his Ph.D. degree in Biological Science from City of Hope National Medical Center at the Beckman Research Institute in Duarte, CA. He holds a Master of Biology and certification of BioTechnology from California State University, Los Angeles.  He graduated as a Bachelor of Science in Biology from Kyung Hee University in Seoul Korea.  He also completed an executive MBA program for CEO in Bio-Technology from Seoul National University, Korea.

Laboratory Director

Dr. Hong Shen is an esteemed Laboratory Director with a diverse and distinguished background in pathology, neuroscience, and clinical research. She holds dual certifications in Anatomic and Clinical Pathology from the American Board of Pathology and brings over two decades of experience in medical practice and research. Dr. Shen earned her medical degree from Zhejiang University School of Medicine in China and a Ph.D. in Neuroscience from the University of Texas Medical Branch in Galveston, Texas. Her rigorous academic foundation is complemented by her residency in Anatomic and Clinical Pathology at Harbor-UCLA Medical Center and a fellowship in Surgical Pathology at the David Geffen School of Medicine at UCLA.

Dr. Shen has served in pivotal roles across multiple healthcare institutions, including her current position as Laboratory Director at Gastroenterology & Hepatology Specialists in Thousand Oaks, California, and Co-Medical Director at Antelope Valley Hospital. Her expertise extends to precision diagnostics and pathology laboratory operations, where she has consistently demonstrated exceptional leadership and innovative problem-solving.

In addition to her clinical work, Dr. Shen has contributed extensively to academic research, publishing more than 10 peer-reviewed journal articles. Her prior research roles at the University of California-Irvine and her postdoctoral fellowship in neuroscience further highlight her commitment to advancing medical science. With a strong focus on patient-centered care and cutting-edge diagnostics, Dr. Shen continues to lead initiatives that improve healthcare outcomes and drive advancements in pathology and laboratory medicine.